Brief Description
Axent Biosciences is a pre-clinical stage biotechnology company developing next generation stem cell therapies to address unmet medical needs in human diseases/disorders. The company was spun out of research discoveries in the lab of UC Berkeley Professor of Chemical and Biomolecular Engineering, Bioengineering, and Neuroscience David Schaffer. Axent's platform technologies in stem cell manufacturing and implantation leverage 20+ years of stem cell expertise and 10+ years of biomaterials engineering to overcome major bottlenecks in the clinical development pipeline to efficiently provide high quality stem cell therapeutics to large populations of patients in need.
Inventors
Dave Schaffer, Maroof Adil, Badriprasad Ananthanarayanan, Barbara Ekerdt, Christina Fuentes, Hunter James Johnson, Sanjay Kumar, Yuguo Lei, Rachel Segalman, Tandis Vazin
Company Founders
Hunter Johnson (UC Berkeley, Ph.D. ’22, Bioengineering), Riya Muckom (UC Berkeley, Ph.D., Chemical and Biomolecular Engineering), Rocío Sampayo, UC Berkeley Professor David Schaffer
Timeline
- 2019. Company founded